aap Implantate AG

XETRA AAQ1.DE

aap Implantate AG Current Liabilities for the year ending December 31, 2023: USD 5.21 M

aap Implantate AG Current Liabilities is USD 5.21 M for the year ending December 31, 2023, a -11.79% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

aap Implantate AG Current Liabilities for the year ending December 31, 2022 was USD 5.91 M, a -18.13% change year over year.
aap Implantate AG Current Liabilities for the year ending December 31, 2021 was USD 7.21 M, a 17.75% change year over year.
aap Implantate AG Current Liabilities for the year ending December 31, 2020 was USD 6.13 M, a 22.23% change year over year.
aap Implantate AG Current Liabilities for the year ending December 31, 2019 was USD 5.01 M, a -6.25% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

XETRA: AAQ1.DE

aap Implantate AG

CEO	Mr. Rubino Di Girolamo
IPO Date	May 11, 1999
Location	Germany
Headquarters	Lorenzweg 5
Employees	87
Sector	Healthcare
Industries Medical Instruments 3D Printing Automotive Parts Composite Materials Glass Hardware & Electronics Pharmaceuticals Plastics

Description

aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Key trends

Past 5 years